Cargando…

Human Y Chromosome Exerts Pleiotropic Effects on Susceptibility to Atherosclerosis

The male-specific region of the Y chromosome (MSY) remains one of the most unexplored regions of the genome. We sought to examine how the genetic variants of the MSY influence male susceptibility to coronary artery disease (CAD) and atherosclerosis. APPROACH AND RESULTS: Analysis of 129 133 men from...

Descripción completa

Detalles Bibliográficos
Autores principales: Eales, James M., Maan, Akhlaq A., Xu, Xiaoguang, Michoel, Tom, Hallast, Pille, Batini, Chiara, Zadik, Daniel, Prestes, Priscilla R., Molina, Elsa, Denniff, Matthew, Schroeder, Juliane, Bjorkegren, Johan L.M., Thompson, John, Maffia, Pasquale, Guzik, Tomasz J., Keavney, Bernard, Jobling, Mark A., Samani, Nilesh J., Charchar, Fadi J., Tomaszewski, Maciej
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818981/
https://www.ncbi.nlm.nih.gov/pubmed/31644355
http://dx.doi.org/10.1161/ATVBAHA.119.312405
_version_ 1783463658708271104
author Eales, James M.
Maan, Akhlaq A.
Xu, Xiaoguang
Michoel, Tom
Hallast, Pille
Batini, Chiara
Zadik, Daniel
Prestes, Priscilla R.
Molina, Elsa
Denniff, Matthew
Schroeder, Juliane
Bjorkegren, Johan L.M.
Thompson, John
Maffia, Pasquale
Guzik, Tomasz J.
Keavney, Bernard
Jobling, Mark A.
Samani, Nilesh J.
Charchar, Fadi J.
Tomaszewski, Maciej
author_facet Eales, James M.
Maan, Akhlaq A.
Xu, Xiaoguang
Michoel, Tom
Hallast, Pille
Batini, Chiara
Zadik, Daniel
Prestes, Priscilla R.
Molina, Elsa
Denniff, Matthew
Schroeder, Juliane
Bjorkegren, Johan L.M.
Thompson, John
Maffia, Pasquale
Guzik, Tomasz J.
Keavney, Bernard
Jobling, Mark A.
Samani, Nilesh J.
Charchar, Fadi J.
Tomaszewski, Maciej
author_sort Eales, James M.
collection PubMed
description The male-specific region of the Y chromosome (MSY) remains one of the most unexplored regions of the genome. We sought to examine how the genetic variants of the MSY influence male susceptibility to coronary artery disease (CAD) and atherosclerosis. APPROACH AND RESULTS: Analysis of 129 133 men from UK Biobank revealed that only one of 7 common MSY haplogroups (haplogroup I1) was associated with CAD—carriers of haplogroup I1 had ≈11% increase in risk of CAD when compared with all other haplogroups combined (odds ratio, 1.11; 95% CI, 1.04–1.18; P=6.8×10(−4)). Targeted MSY sequencing uncovered 235 variants exclusive to this haplogroup. The haplogroup I1–specific variants showed 2.45- and 1.56-fold respective enrichment for promoter and enhancer chromatin states, in cells/tissues relevant to atherosclerosis, when compared with other MSY variants. Gene set enrichment analysis in CAD-relevant tissues showed that haplogroup I1 was associated with changes in pathways responsible for early and late stages of atherosclerosis development including defence against pathogens, immunity, oxidative phosphorylation, mitochondrial respiration, lipids, coagulation, and extracellular matrix remodeling. UTY was the only Y chromosome gene whose blood expression was associated with haplogroup I1. Experimental reduction of UTY expression in macrophages led to changes in expression of 59 pathways (28 of which overlapped with those associated with haplogroup I1) and a significant reduction in the immune costimulatory signal. CONCLUSIONS: Haplogroup I1 is enriched for regulatory chromatin variants in numerous cells of relevance to CAD and increases cardiovascular risk through proatherosclerotic reprogramming of the transcriptome, partly through UTY.
format Online
Article
Text
id pubmed-6818981
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-68189812019-11-26 Human Y Chromosome Exerts Pleiotropic Effects on Susceptibility to Atherosclerosis Eales, James M. Maan, Akhlaq A. Xu, Xiaoguang Michoel, Tom Hallast, Pille Batini, Chiara Zadik, Daniel Prestes, Priscilla R. Molina, Elsa Denniff, Matthew Schroeder, Juliane Bjorkegren, Johan L.M. Thompson, John Maffia, Pasquale Guzik, Tomasz J. Keavney, Bernard Jobling, Mark A. Samani, Nilesh J. Charchar, Fadi J. Tomaszewski, Maciej Arterioscler Thromb Vasc Biol Clinical and Population Studies The male-specific region of the Y chromosome (MSY) remains one of the most unexplored regions of the genome. We sought to examine how the genetic variants of the MSY influence male susceptibility to coronary artery disease (CAD) and atherosclerosis. APPROACH AND RESULTS: Analysis of 129 133 men from UK Biobank revealed that only one of 7 common MSY haplogroups (haplogroup I1) was associated with CAD—carriers of haplogroup I1 had ≈11% increase in risk of CAD when compared with all other haplogroups combined (odds ratio, 1.11; 95% CI, 1.04–1.18; P=6.8×10(−4)). Targeted MSY sequencing uncovered 235 variants exclusive to this haplogroup. The haplogroup I1–specific variants showed 2.45- and 1.56-fold respective enrichment for promoter and enhancer chromatin states, in cells/tissues relevant to atherosclerosis, when compared with other MSY variants. Gene set enrichment analysis in CAD-relevant tissues showed that haplogroup I1 was associated with changes in pathways responsible for early and late stages of atherosclerosis development including defence against pathogens, immunity, oxidative phosphorylation, mitochondrial respiration, lipids, coagulation, and extracellular matrix remodeling. UTY was the only Y chromosome gene whose blood expression was associated with haplogroup I1. Experimental reduction of UTY expression in macrophages led to changes in expression of 59 pathways (28 of which overlapped with those associated with haplogroup I1) and a significant reduction in the immune costimulatory signal. CONCLUSIONS: Haplogroup I1 is enriched for regulatory chromatin variants in numerous cells of relevance to CAD and increases cardiovascular risk through proatherosclerotic reprogramming of the transcriptome, partly through UTY. Lippincott Williams & Wilkins 2019-11 2019-09-05 /pmc/articles/PMC6818981/ /pubmed/31644355 http://dx.doi.org/10.1161/ATVBAHA.119.312405 Text en © 2019 The Authors. Arteriosclerosis, Thrombosis, and Vascular Biology is published on behalf of the American Heart Association, Inc., by Wolters Kluwer Health, Inc. This is an open access article under the terms of the Creative Commons Attribution (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution, and reproduction in any medium, provided that the original work is properly cited.
spellingShingle Clinical and Population Studies
Eales, James M.
Maan, Akhlaq A.
Xu, Xiaoguang
Michoel, Tom
Hallast, Pille
Batini, Chiara
Zadik, Daniel
Prestes, Priscilla R.
Molina, Elsa
Denniff, Matthew
Schroeder, Juliane
Bjorkegren, Johan L.M.
Thompson, John
Maffia, Pasquale
Guzik, Tomasz J.
Keavney, Bernard
Jobling, Mark A.
Samani, Nilesh J.
Charchar, Fadi J.
Tomaszewski, Maciej
Human Y Chromosome Exerts Pleiotropic Effects on Susceptibility to Atherosclerosis
title Human Y Chromosome Exerts Pleiotropic Effects on Susceptibility to Atherosclerosis
title_full Human Y Chromosome Exerts Pleiotropic Effects on Susceptibility to Atherosclerosis
title_fullStr Human Y Chromosome Exerts Pleiotropic Effects on Susceptibility to Atherosclerosis
title_full_unstemmed Human Y Chromosome Exerts Pleiotropic Effects on Susceptibility to Atherosclerosis
title_short Human Y Chromosome Exerts Pleiotropic Effects on Susceptibility to Atherosclerosis
title_sort human y chromosome exerts pleiotropic effects on susceptibility to atherosclerosis
topic Clinical and Population Studies
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6818981/
https://www.ncbi.nlm.nih.gov/pubmed/31644355
http://dx.doi.org/10.1161/ATVBAHA.119.312405
work_keys_str_mv AT ealesjamesm humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT maanakhlaqa humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT xuxiaoguang humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT michoeltom humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT hallastpille humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT batinichiara humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT zadikdaniel humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT prestespriscillar humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT molinaelsa humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT denniffmatthew humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT schroederjuliane humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT bjorkegrenjohanlm humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT thompsonjohn humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT maffiapasquale humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT guziktomaszj humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT keavneybernard humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT joblingmarka humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT samaninileshj humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT charcharfadij humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis
AT tomaszewskimaciej humanychromosomeexertspleiotropiceffectsonsusceptibilitytoatherosclerosis